Quantum Biopharma Reports Strong Third Quarter Results Maintaining 'No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio Quarter Shows Company's Continued Strong Financial Position and Momentum with its MS Clinical Trials and unbuzzd(TM) Recreational Beverage and Alcohol Metabolizer GlobeNewswire November 07, 2025 TORONTO, Nov. 07, 2025 […]

RYTHM, Inc. Reports Third Quarter 2025 Results GlobeNewswire November 07, 2025 ROLLING MEADOWS, Ill., Nov. 07, 2025 (GLOBE NEWSWIRE) — RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”) (formerly known as Agrify Corporation), which delivers well-being to consumers through its portfolio of iconic licensed brands and hemp-derived THC products including Senorita THC Margaritas and RYTHM,

Hain Celestial Reports Fiscal First Quarter 2026 Financial Results GlobeNewswire November 07, 2025 HOBOKEN, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) — The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, today reported financial results for its fiscal first quarter ended

Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025 Studies spanning cardiovascular, aging, and cancer biology highlight how Seer's Proteograph(R) platform is enabling discovery at population scale GlobeNewswire November 07, 2025 REDWOOD CITY, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), the pioneer and

Onex Reports Third Quarter 2025 Results GlobeNewswire November 07, 2025 All amounts in U.S. dollars unless otherwise stated TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today announced its financial results for the third quarter ended September 30, 2025. “Onex' third quarter results reflect ongoing progress across the business,” said Bobby Le

Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates GlobeNewswire November 07, 2025 — New preclinical data for PM577 in Wilson's Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1'26, with initial clinical data expected in 2027 — — Nominated PM647 as development candidate for Alpha-1

Ocular Therapeutix(TM) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire November 07, 2025 BEDFORD, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to one newly hired non-executive employee. The award was

MADD Canada Unveils Roadside Memorial Sign in Trenton in Honour of Rebecca Beatty Killed in Impaired Driving Crash GlobeNewswire November 07, 2025 OAKVILLE, Ontario, Nov. 07, 2025 (GLOBE NEWSWIRE) — A new MADD Canada roadside memorial sign will be unveiled today in Trenton in honour of 22-year-old Rebecca Beatty, who was tragically killed in an

Memo Therapeutics AG Presents Long Term Follow-Up Data from its Phase II SAFE KIDNEY Trial of Potravitug and Real World Data on the Challenges and Re-source Utilization of Managing Kidney Transplant Recipients at ASN Kidney Week Meeting GlobeNewswire November 07, 2025 PRESS RELEASE Memo Therapeutics AG Presents Long Term Follow-Up Data from its Phase II

AMC Networks Inc. Reports Third Quarter 2025 Results GlobeNewswire November 07, 2025 NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) — AMC Networks Inc. (“AMC Networks” or the “Company”) (NASDAQ: AMCX) today reported financial results for the third quarter ended September 30, 2025. Chief Executive Officer Kristin Dolan said: “Our performance in the third quarter marks